Physician profile
Joyce Lam
NPI 1265127740
$4,220.01
in general payments reported to CMS, 2019-2025
12 companies · $3,317 in 2025
The $3,317 reported for 2025 was more than what 97% of Gerontology (Nurse Practitioner) providers received nationally (typical 2025 total: $180).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $18.83 · 2024: $885 · 2025: $3,317.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,729 · Travel and Lodging: $1,338 · Education: $153.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,729.36 |
| Travel and Lodging | $1,337.65 |
| Education | $153.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $2,701.92 | 2024-2025 | Synchromedii, Inceptiv, Intellis Adaptivestim |
| Abbvie INC. | $402.18 | 2023-2025 | |
| Scilex Pharmaceuticals INC. | $236.70 | 2024-2025 | |
| Nevro Corp. | $229.26 | 2024 | Senza |
| Pfizer INC. | $196.78 | 2024-2025 | |
| Collegium Pharmaceutical, INC. | $178.57 | 2024-2025 | Xtampza, Belbuca |
| Averitas Pharma INC. | $76.95 | 2024-2025 | Qutenza |
| Stryker Corporation | $73.26 | 2025 | Optablate |
| Valinor Pharma, LLC | $52.01 | 2025 | Movantik |
| Lundbeck LLC | $28.70 | 2024 | Vyepti |
| Biotronik Nro, INC. | $24.57 | 2025 | Prospera |
| Boston Scientific Corporation | $19.11 | 2024 | Wavewriter Alpha Prime 16 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joyce Lam listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.